One prospective study demonstrated that the addition of KRAS testing on endoscopic ultrasound and fine needle aspiration (EUS-FNA) material increased the sensitivity, negative predictive value and accuracy of the cytopathology used to diagnosis pancreatic adenocarcinoma (Bournet et al. 2015). This evidence concerns the gene KRAS and pancreatic adenocarcinoma.